Insmed, Inc. (NASDAQ:INSM – Free Report) – William Blair issued their Q3 2025 EPS estimates for shares of Insmed in a research report issued on Tuesday, August 19th. William Blair analyst M. Phipps forecasts that the biopharmaceutical company will post earnin…